Orion Therapeutics, Inc. — Form D
Orion Therapeutics, Inc. of KNOXVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-25. The offering totals $250K, of which $85K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-25
- Form: D
- Accession: 0001958173-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $85K
- Remaining: $165K
- Investors: 4
- Date of first sale: 2024-09-10
- Revenue range: $1 - $1,000,000
- SEC file number: 021-524886
Issuer
- Name: Orion Therapeutics, Inc.
- CIK: 0001958173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2641 OSPREY VISTA WAY, KNOXVILLE, TN, 37920
- Phone: 865-771-7024
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Richard Kern Fisher | Director | Knoxville, TN |
| Michael Kern McCaman | Director | Knoxville, TN |
| Deidra Kern Mountain | Director | Knoxville, TN |
| Richard Kern Fisher | Executive Officer | Knoxville, TN |
| Michael Kern McCaman | Executive Officer | Knoxville, TN |
Other filings by this issuer (1)
More